Product Information
DAPTOMYCIN 500 MG VIAL is a generic product labeled by Xellia Pharmaceuticals USA LLC, priced at $20.7686 per EA under NDC 70594006001. Its NADAC has been published 93 times since Apr 17, 2024.
Strength
500 mg/10mL
Manufacturer
Xellia Pharmaceuticals USA LLCNDC
70594006001
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
1/21/2026
Active Ingredients
DAPTOMYCINApproval Type
New Drug (NDA)
FDA Application
NDA217415On Market Since
11/3/2023
Pharmacological Classes
Price Statistics
The NADAC for DAPTOMYCIN 500 MG VIAL has been published 93 times since Apr 17, 2024, and over the history we have for it it has declined 16.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.7686 per EA |
|---|---|
| All-time high | $28.3900 (Sep 11, 2024) |
| All-time low | $20.1020 (Oct 22, 2025) |
| 52-week high | $24.2743 |
| 52-week low | $20.1020 |
| Median price | $23.8720 |
| Average price | $23.2457 |
| Largest weekly change | -17.2% (Oct 22, 2025) |
| Weeks tracked | 93 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DAPTOMYCIN 500 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DAPTOMYCIN 500 MG VIAL, manufactured by Xellia Pharmaceuticals USA LLC, is $20.7686 per EA (NDC 70594006001), effective Jan 21, 2026.
How has the price of DAPTOMYCIN 500 MG VIAL changed over time?
Over the history we have for it, the NADAC for DAPTOMYCIN 500 MG VIAL has declined 16.4%. It has been tracked across 93 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DAPTOMYCIN 500 MG VIAL?
Since Apr 17, 2024, the NADAC for DAPTOMYCIN 500 MG VIAL has ranged from a low of $20.1020 (Oct 22, 2025) to a high of $28.3900 (Sep 11, 2024), with a median of $23.8720 per EA.
Are there cheaper alternatives to DAPTOMYCIN 500 MG VIAL?
2 NADAC-published products share the same active ingredient, strength, and dosage form as DAPTOMYCIN 500 MG VIAL, but none are currently priced below it.
Who manufactures DAPTOMYCIN 500 MG VIAL?
DAPTOMYCIN 500 MG VIAL (NDC 70594006001) is labeled by Xellia Pharmaceuticals USA LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification